Hello and welcome to the Kratomaton Biweekly update for December 11th, 2017!The year is coming to a close as we approach the holiday season – but there’s still a lot happening in the world of kratom! For starters, a staunch community pushback effort against the FDA’s recent health advisory continues. And, regarding Kratomaton, we’ve got some freshly-posted “best of” lists we’d love to share with you. Because our next weekly update is scheduled for the 25th, this will be our last update of this year. That said, we’d like to take the opportunity to wish you & yours a happy holiday season – and we hope to see you in the new year!
KRATOM IN THE NEWS
FDA Kratom Ban UpdatesIt’s been nearly a month since the United States Food and Drug Administration released their original statement on the “deadly risks associated with kratom” on November 14th, 2017, reviving the possibility of an upcoming kratom ban in the US. In that time, the online kratom community has been outspoken in denouncing the claims made by the FDA against kratom. Several petitions and advocacy campaigns have been created and promoted, and hundreds of tweets are being directed towards the FDA as well as towards Scott Gottlieb, current commissioner of the FDA. However, there have been no real updates on the matter from the FDA in response to the community outcry. It’s possible that the eight-factor analysis process Gottlieb mentioned in a recent interview is still ongoing:
We’re currently working with the DEA to look at a scheduling process now. We’re coming up with what we call an eight-factor analysis which assesses the product. We’ve made that available to the DEA for their consideration. They’ll make a scheduling decision based on our analysis. – Scott Gottlieb, Current FDA CommissionerAlthough the organization itself has given no updates regarding a kratom ban, Gottlieb has since tweeted several times this month regarding “illegally [marketed] … products that claim to effectively treat opioid use disorder,” which may be implicitly referring to kratom:
#FDA will continue to act when it learns of the deceptive sale or advertising of products that claim to effectively treat opioid use disorder, but which have not been proven safe and effective for these purposes.— Scott Gottlieb, M.D. (@SGottliebFDA) December 8, 2017
As bureaucratic pressure mounts, only one thing is certain: the future of kratom sales in the USA is unclear.
KRATOM COMMUNITY CALL-TO-ACTION
As the online kratom community continues campaigning for FDA reevaluation and education regarding kratom and it’s public perceptions, several more petitions and forms have been created.
If you’re a US citizen and would like to lend your aid towards preventing a kratom ban, you may do so via these links:
Botanical Education – Kratom Call to Action: FDA Advisory 2017
VENDOR UPDATESWe’ll be working well into the new year with online kratom vendors to build both better connections and improved online solutions for the community. Most of this is taking place behind the scenes, so be patient! If you’re an online kratom vendor and would like to work with us, please don’t hesitate to contact us here.
STRAIN UPDATESNo new strains were added this week! If we’re totally slacking and missed one, let us know!
“BEST OF” BLOG POSTSWe’re committed to keeping Kratomaton loaded with new content for our users – and so we’ve been cooking up some articles we’d love to share with you! Two blog articles in our new “best of” series have been posted already, with more to come. You can check them out here:
BORING STUFF – BUG FIXES N’ MORE
- Fixed an issue that prevented users from being able to activate their accounts and login (oops!)
That’s it for this week’s update. Happy holidays to you and yours, and thanks for reading! Love, Kratomaton